IP Pharma Challenges ... in Stockholm

The IPKat is delighted to learn that the Stockholm University IP Law Review (SIPLR), a student-led journal co-founded by GuestKat Frantzeska Papadopoulou, is organizing an exciting IP seminar that will take place in Stockholm next week, on Tuesday 4 June.

The journal's Editor-In-Chief, Silvia A. Carretta, explains more in detail what the event is about and what lies ahead for SIPLR:

Kats are also famous for liking conferences
(and coffee breaks)
The Stockholm University IP Law Review is excited and proud to share with The IPKat family news of our next IP seminar:



The seminar will take place on June 4, at Stockholm University.

For those of you who will be in town and want to join, we would be more than happy to have you there! You can confirm your attendance by emailing info@stockholmiplawreview.com.

Nowadays, pharma-related IP challenges are some of the most prominent and discussed topics in the field of IP. Thus, exploring them from different angles and perspectives is a rather intriguing opportunity. Some of the best-known professionals in the field of IP are participating in the seminar to share with us their knowledge and experience regarding this interesting topic. 

Here is the list of speakers: 
  • Carl Wendt - Groth & Co
  • Kristina Björnerstedt - Skriptor Zigila
  • Thomas Hedner - Institute for Management of Innovation and Technology, Gothenburg 
  • John Hornby - Lambert Hornby IP Law, London 
  • Bengt Domeij - Faculty of Law, Uppsala University
Are you excited already? You can find more information about the seminar here, the program is here, and the speakers & topics discussed here

But the good news is not over yet! The SIPLR is pleased to announce the publication of its third issue, June 2019. Visit our website here to read the latest issue, and don’t forget to check out our previous issues too.

And one last thing! For those of you who cannot get enough of IP news, find us on LinkedIn here and Facebook and we can keep you updated on IP latest news.
IP Pharma Challenges ... in Stockholm IP Pharma Challenges ... in Stockholm Reviewed by Eleonora Rosati on Thursday, May 30, 2019 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.